Basic symptoms and P300 abnormalities in young schizophrenic patients

Comprehensive Psychiatry

Volumn 40, Issue 5, 1999, Pages 363-371

  Pallanti, S ^a   Quercioli, L ^a   Pazzagli, A ^a  

^a Psichiatria P   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; MALE; MENTAL DEFICIENCY; NEGATIVE SYNDROME; SCHIZOPHRENIA; SCORING SYSTEM; SYMPTOMATOLOGY;

EID: 0032822677     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-440X(99)90142-6     Document Type: Article

References (52)

1. Jaspers K. Allgemeine Psychopathologie. Berlin, Germany: Springer, 1913.
2. Marková IS, Berrios GE. The meaning of insight in clinical psychiatry. Br J Psychiatry 1992;160:850-860.
3. Huber G. Reine defektsyndrome und basisstadien endogener psychosen. Fortschr Neurol Psychiatr 1966;34:409-426.
4. Süllwold L. Symptome schizophrener erkankungen: uncharakteristische basisstörungen. Monographien aus dem Gesamtgebiet der Psychiatrie. Vol. 13. Berlin, Germany: Springer, 1977.
5. Schunemann-Wurmthaler S. Subjektive basisstörungen der schizophrenie. Europäische Hochschulschriften. Frankfurt, Germany: Lang, 1984.
6. Süllwold L. Schwach ausgeprägte schizophrene symptome. Wege zur spezifität? In: Huber G (ed): Basisstadien endogener psychosen un das Borderline-problem. Stuttgart, Germany: Schottauer, 1985.
7. Süllwold L, Huber G. Schizophrene Basisstörungen. Berlin, Germany: Springer-Verlag, 1986.
8. Süllwold L, Herrlich J. Providing schizophrenic patients with a concept of illness. An essential element of therapy. Br J Psychiatry 1992;161 (18 Suppl):129-132.
9. Loas G, Berner P, Rein W, Yon V, Boyer P, Lecrubier Y. French translation of the Frankfurt Complaint Questionnaire (Frankfurter Beschwerde Fragebogen, FBF, Süllwold, 1986). Enchephale 1997;23:364-374.
10. Peralta V, Cuesta MJ. Trastornos cognitivos en la esquizofrenia: valoracion por medio del inventario psicopatologico de Frankfurt. Resultados inciales. Acta Luso Esp Neurol Psiquiatr Cienc Afines 1989;15:255-262.
11. Süllwold L. FBF: Questionario dei Sintomi-Base. Edited by Stanghellini G, Strik WK, Cabras PL. Florence. Italy: Organizzazioni Speciali, 1991.
12. Brenner HD, Böker W, Müller J, Spichtig L, Würgler S. On autoprotective efforts of schizophrenics, neurotics and controls. Acta Psychiatr Scand 1987;75:405-414.
13. Simhandl C, Dietzel M, Lesch OM, Musalek M, Strobl R. Cognitive disturbances in chronic schizophrenia: formal thought disorder and basic symptoms. Psychopathology 1986;19: 206-212.
14. Stanghellini G, Quercioli L, Ricca V, Strik WK, Cabras PL. Basic symptoms and negative symptoms in the light of language impairment. Compr Psychiatry 1991;32:141-146.
15. Eikmeier G, Lodemann E, Olbrich HM, Pach J, Zerbin D, Gastpar M. Postimperative negative variation and skin conductance response in chronic DSM-III-R schizophrenia. Acta Psychiatr Scand 1992;86:346-350.
16. Wiedl KH, Schöttner B. Coping with symptoms related to schizophrenia. Schizophr Bull 1991;17:525-538.
17. Pallanti S, Quercioli L, Pazzagli A. Relapse in young schizophrenic patients: a prospective study of stressful life events, P300 measures, and coping. Am J Psychiatry 1997;154: 792-798.
18. Cuesta MJ, Peralta V, Juan JA. Abnormal subjective experiences in schizophrenia: its relationships with neuropsychological disturbances and frontal signs. Eur Arch Psychiatry Clin Neurosci 1996b;246;2:101-105.
19. Van den Bosch RJ, Rozendaal N. Subjective cognitive dysfunction, eye tracking, and slow brain potentials in schizophrenics and schizoaffective patients. Biol Psychiatry 1988;24: 741-746.
20. Wolfersdorf M, Straub R, Barg T, Studemund H, Ruppe A. Electrodermal reactivity in schizophrenic women with socalled basic symptoms. Fortschr Neurol Psychiatr 1995;63:363-367.
21. Gross G, Huber G, Armbruster B. Schizoaffective psychoses: long term prognosis and symptomatology. In: Marneros A, Tsuang MT (eds): The Schizoaffective Psychoses. Berlin, Germany: Springer, 1986:188-203.
22. Ebel H, Gross G, Klosterkötter J, Huber G. Basic symptoms in schizophrenic and affective psychoses. Psychopathology 1989;22:224-232.
23. Pazzagli A, Pallanti S. Memory disturbances and schizophrenia. Acts of 5th World Biological Psychiatry Congress. Biol Psychiatry 1991;2:106-108.
24. Duncan CC. Event-related brain potentials: a window on information processing in schizophrenia. Schizophr Bull 1988; 14:199-203.
25. Heidrich A, Strik WK. Auditory P300 topography and neuropsychological test performance: evidence for left hemispheric dysfunction in schizophrenia. Biol Psychiatry 1997;41: 327-335.
26. Shajahan PM, O'Carroll RE, Glabus MF, Ebmeier KP, Blackwood DH. Correlation of auditory 'oddball' P300 with verbal memory deficits in schizophrenia. Psychol Med 1997;27: 579-586.
27. Hirayasu Y, Asato N, Ohta H, Hokama H, Arakaki H, Okura C. Abnormalities of auditory event-related potentials in schizophrenia prior to treatment. Biol Psychiatry 1998;43:244-253.
28. Juckel G, Müller Schubert A, Gaebel W, Hegerl U. Residual symptoms and P300 in schizophrenic outpatients. Psychiatry Res 1996;65:23-32.
29. Turetsky B, Colbath EA, Gur RE. P300 subcomponent abnormalities in schizophrenia. II. Longitudinal stability and relationship to symptom change. Biol Psychiatry 1998;43: 31-39.
30. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962;10:799-812.
31. Andreasen NC. Schizofrenia. Scale per la valutazione dei Sintomi Positivi e Negativi. Milano, Italy: Cortina, 1987.
32. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R (SCID). Washington, DC: American Psychiatric Press, 1990.
33. Rey MJ, Schulz P, Costa C. Guidelines for the dosage of neuroleptics, I: chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychopharmacol 1989;4:95-104.
34. Klosterkötter J. Basissymptome und endphanomene der schizophrenie. Berlin, Germany: Springer, 1988.
35. Mundt CH, Kasper S. Zur schizophreniespezifität von negativen und basisymptomen. Nervenarzt 1987;58:489-495.
36. Peralta V, Cuesta MJ. A polydiagnostic approach to self-perceived cognitive disorders in schizophrenia. Psychopathology 1992;25:232-238.
37. Williams RM, Alagaratnam W, Hemsley DR. Relationship between subjective self-report of cognitive dysfunction and objective information processing performance in a group of hospitalized schizophrenic patients. Eur Arch Psychiatry Neurol Sci 1984;234:48-53.
38. Gross G, Huber G, Klosterkotter J. The early phase of schizophrenia and prediction of outcome. Int Clin Psychopharmacol 1998;13:S13-S21 (1 Suppl).
39. Mass R, Hitschfeld K, Wall E, Wagner HB. Validity of assessment of schizophrenic basic symptoms. Nervenarzt 1997; 68:205-211.
40. Romani S, Merello S, Gozzoli L, Zerbi F, Grassi M, Cosi V. P300 and CT scan in patients with chronic schizophrenia. Br J Psychiatry 1987;151:506-513.
41. Souza VBN, Muir WJ, Walker MT, Glabus MF, Roxborough HM, Sharp CW, et al. Auditory P300 event-related potentials and neuropsychological performance in schizophrenia and bipolar affective disorder. Biol Psychiatry 1995;37:300-310.
42. Stefánsson SB, Jónsdóttir TJ. Auditory event-related potentials, auditory digit span, and clinical symptoms in chronic schizophrenic men on neuroleptic medication. Biol Psychiatry 1996;40:19-27.
43. Blackwood DHR, Whalley LJ, Christie JE, Blackburn IM, St Clair DM, McInnes A. Changes in auditory P3 eventrelated potential in schizophrenia and depression. Br J Psychiatry 1987;150:154-160.
44. Egan MF, Duncan CC, Suddath RL, Kirch DG, Mirsky AF, Wyatt RJ. Event related potential abnormalities correlate with structural brain alterations and clinical features in patients with chronic schizophrenia. Schizophr Res 1994;11:259-271.
45. Pfefferbaum A, Ford JM, White PM, Roth WT. P3 in schizophrenia is affected by stimulus modality response requirements, medication status and negative symptoms. Arch Gen Psychiatry 1989;46:1035-1044.
46. Strik WK, Dierks T, Kulke H, Maurer K, Fallgatter A. The predictive value of P300-amplitudes in the course of schizophrenic disorders. J Neural Transm 1996;103:1351-1359.
47. Gross G. Prodrome und vorpostenprodrome schizophrener enkrankungen. In: Huber G (ed): Schizophrenie un zyklothimie. Ergebnisse und probleme. Stuttgart, Germany: Thieme, 1969:77-187.
48. Gross G. The onset of schizophrenia. Schizophr Res 1997;28:187-198.
49. Friedman D, Vaughan HG, Erlenmeyer-Kimling L. Cognitive brain potentials in children at risk for schizophrenia: preliminary findings. Schizophr Bull 1982;8:514-531.
50. Saitoh O, Niwa SI, Hiramatsu KI, Kameyama T, Rymar K, Itoh K. P300 in siblings of schizophrenic probands. Adv Biol Psychiatry 1984;15:46-59.
51. Schreiber H, Stolz G, Kornhuber HH, Born J. Electrophysiologic correlates of selective attention in children and adolescents at increased risk of schizophrenia. Z Kinder Jugenpsychiatr 1996;24:282-292.
52. Pallanti S, Quercioli L, Pazzagli A. Effects of clozapine on awareness of illness and cognition in schizophrenia. Psychiatry Res. In press.